1-arilnaftiridina-3-carboxamidas 7-substituídas e seu uso

1-arilnaftiridina-3-carboxamidas 7-substituídas e seu uso. o presente pedido se refere a novas 1-arilnaftiridina-3-carboxamidas 7-substituídas, a processos para sua preparação, a seu uso, isoladamente ou em combinações para o tratamento e/ou a prevenção de doenças e a seu uso para a produção de medi...

Full description

Saved in:
Bibliographic Details
Main Authors THOMAS MONDRITZKI, ALEXANDER STRAUB, HENRIK TELLER, MATTHIAS BEAT WITTWER, ALEXANDROS VAKALOPOULOS, TILL FREUDENBERGER, MARKUS BRECHMANN, MELISSA BOULTADAKIS ARAPINIS, TOBIAS MARQUARDT, MAXIMILIAN ANDREAS KULLMANN, HANNA TINEL
Format Patent
LanguagePortuguese
Published 20.08.2019
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

Abstract 1-arilnaftiridina-3-carboxamidas 7-substituídas e seu uso. o presente pedido se refere a novas 1-arilnaftiridina-3-carboxamidas 7-substituídas, a processos para sua preparação, a seu uso, isoladamente ou em combinações para o tratamento e/ou a prevenção de doenças e a seu uso para a produção de medicamentos para o tratamento e/ou a prevenção de doenças, em particular, para o tratamento e/ou a prevenção de distúrbios cardiovasculares e/ou distúrbios renais. The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
AbstractList 1-arilnaftiridina-3-carboxamidas 7-substituídas e seu uso. o presente pedido se refere a novas 1-arilnaftiridina-3-carboxamidas 7-substituídas, a processos para sua preparação, a seu uso, isoladamente ou em combinações para o tratamento e/ou a prevenção de doenças e a seu uso para a produção de medicamentos para o tratamento e/ou a prevenção de doenças, em particular, para o tratamento e/ou a prevenção de distúrbios cardiovasculares e/ou distúrbios renais. The present application relates to novel 7-substituted 1-arylnaphthyridine-3-carboxamides, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prevention of diseases, and to their use for the production of medicaments for the treatment and/or prevention of diseases, in particular for the treatment and/or prevention of cardiovascular disorders and/or renal disorders.
Author ALEXANDROS VAKALOPOULOS
HENRIK TELLER
MATTHIAS BEAT WITTWER
MELISSA BOULTADAKIS ARAPINIS
TOBIAS MARQUARDT
HANNA TINEL
MAXIMILIAN ANDREAS KULLMANN
TILL FREUDENBERGER
THOMAS MONDRITZKI
ALEXANDER STRAUB
MARKUS BRECHMANN
Author_xml – fullname: THOMAS MONDRITZKI
– fullname: ALEXANDER STRAUB
– fullname: HENRIK TELLER
– fullname: MATTHIAS BEAT WITTWER
– fullname: ALEXANDROS VAKALOPOULOS
– fullname: TILL FREUDENBERGER
– fullname: MARKUS BRECHMANN
– fullname: MELISSA BOULTADAKIS ARAPINIS
– fullname: TOBIAS MARQUARDT
– fullname: MAXIMILIAN ANDREAS KULLMANN
– fullname: HANNA TINEL
BookMark eNrjYmDJy89L5WSwMtRNLMrMyUtMK8ksykzJzEvUNdZNTixKyq9IzM1MSSxWMNctLk0qLsksKT28FsRPVShOLVUoLc7nYWBNS8wpTuWF0twMqm6uIc4euqkF-fGpxQWJyal5qSXxTkGGhkYGhpYGBiaWFkaORsbEqgMAEoAynQ
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID BR112019004982A2
GroupedDBID EVB
ID FETCH-epo_espacenet_BR112019004982A23
IEDL.DBID EVB
IngestDate Fri Jul 19 13:00:13 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Portuguese
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_BR112019004982A23
Notes Application Number: BR20191104982
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190820&DB=EPODOC&CC=BR&NR=112019004982A2
ParticipantIDs epo_espacenet_BR112019004982A2
PublicationCentury 2000
PublicationDate 20190820
PublicationDateYYYYMMDD 2019-08-20
PublicationDate_xml – month: 08
  year: 2019
  text: 20190820
  day: 20
PublicationDecade 2010
PublicationYear 2019
RelatedCompanies BAYER AKTIENGESELLSCHAFT
BAYER PHARMA AKTIENGESELLSCHAFT
RelatedCompanies_xml – name: BAYER PHARMA AKTIENGESELLSCHAFT
– name: BAYER AKTIENGESELLSCHAFT
Score 3.076244
Snippet 1-arilnaftiridina-3-carboxamidas 7-substituídas e seu uso. o presente pedido se refere a novas 1-arilnaftiridina-3-carboxamidas 7-substituídas, a processos...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title 1-arilnaftiridina-3-carboxamidas 7-substituídas e seu uso
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190820&DB=EPODOC&locale=&CC=BR&NR=112019004982A2
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1ZS8QwEB6WVdQ3XRXPpQ_at-Bu08MVitiLRdiDssq-LWnTQmFtSw_0T_kr_GNOStfjRd8ySQiThJn5JscMwJWBuxorSkSMeKQQNeSoB2NGCULXKNYDymiTh2wy1cdP6uNSW3Yg3fyFaeKEvjbBEVGiQpT3qtHX-fchltO8rSxvggSrsntvYTpy6x0PRQLvgexYpjufOTNbtm3T8uWpbyKsEK2Ih2-VB1TZWwilDSER7rMlfqbkP82Ktw_bcxwxrQ6gk1c92LU32dd6sDNpL72x2MpfeQh3Q4K-7TplcZUUCZodRigJWRFkb-wl4ayUDFKiKhD3_x_vgo6kMqqlusyO4NpzF_aYIBOrr1mvLP83z_QYummWRicgUZEwQ40ZZxQBgBFiQdXDkGqcU66NtFPo_z3W2X8dzmFPkOLwVBlcQLcq6ugSrW8V9Jsl-wQyzYdk
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1LT8MwDLamgRg3GCDGY_QAvUVsTR8MqUK0XVVg7aZqoN2m9CVVgnZqO8Gf4lfwx3CqjccFbkkcRU4i25_jJAY413BXE0mKiZYMJCKHEerBhFGC0DVO1IAyWuchcz3VeZTvZ8qsAdn6LUz9T-hr_TkiSlSI8l7V-nrxfYhl1Xcry8sgxab8xp7qlrjyjvs8gXdPtAx9OBlbY1M0Td3wRc_XEVZwKuLhK-kWVfYGwmyNS8TwyeAvUxY_zYq9A5sTHDGrdqGxqNrQMtfZ19qw5a6C3lhcyV-5B9d9gr7tc8aSKi1SNDuMUBKyIsjf2EsasVLQSImqgMf_P955PRbKeCksy3wfLuzh1HQIMjH_mvXc8H_zTA-gmeVZfAgC5Qkz5IRFjCIA0EIsyGoYUiWKaKQMlA50_x7r6L8OZ9Bypu5oPrrzHo5hm5P4QarUO4FmVSzjU7TEVdCtl-8Tt-iKVw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=1-arilnaftiridina-3-carboxamidas+7-substitu%C3%ADdas+e+seu+uso&rft.inventor=THOMAS+MONDRITZKI&rft.inventor=ALEXANDER+STRAUB&rft.inventor=HENRIK+TELLER&rft.inventor=MATTHIAS+BEAT+WITTWER&rft.inventor=ALEXANDROS+VAKALOPOULOS&rft.inventor=TILL+FREUDENBERGER&rft.inventor=MARKUS+BRECHMANN&rft.inventor=MELISSA+BOULTADAKIS+ARAPINIS&rft.inventor=TOBIAS+MARQUARDT&rft.inventor=MAXIMILIAN+ANDREAS+KULLMANN&rft.inventor=HANNA+TINEL&rft.date=2019-08-20&rft.externalDBID=A2&rft.externalDocID=BR112019004982A2